Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Malignant Lymphoma

  Free Subscription


16.02.2026

1 Am J Hematol
4 Blood
1 Bone Marrow Transplant
2 Br J Haematol
1 Cancer
1 Cancer Lett
3 Eur J Haematol
1 Hum Pathol
1 Int J Radiat Oncol Biol Phys
1 J Am Acad Dermatol
1 Lab Invest
1 Leukemia
2 Radiother Oncol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. CHONG EA, Tomasulo EB, Barta SK
    2026 Update on the Management of Diffuse Large B-Cell Lymphoma.
    Am J Hematol. 2026 Feb 7. doi: 10.1002/ajh.70229.
    PubMed         Abstract available


    Blood

  2. YENWONGFAI LN, Francischetti IMB
    Follicular lymphoma transformed to classic Hodgkin lymphoma.
    Blood. 2026;147:800.
    PubMed        

  3. DIEFENBACH C, Jegede O, Wang V, Ansell SM, et al
    A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma.
    Blood. 2026 Feb 9:blood.2025029546. doi: 10.1182/blood.2025029546.
    PubMed         Abstract available

  4. DORANDO HK, Andrews JM, Khatavkar OU, Borcherding N, et al
    Multi-omic Study of Cutaneous T-Cell Lymphoma Reveals Single Cell Clonal Evolution in Progression and Therapy Resistance.
    Blood. 2026 Feb 9:blood.2025029012. doi: 10.1182/blood.2025029012.
    PubMed         Abstract available

  5. SORIAL MN, Malpica Castillo LE, Chiattone C, Julia E, et al
    Early time to relapse as a survival prognosticator in nodal mature T-cell lymphomas: results from the PETAL consortium.
    Blood. 2026;147:755-767.
    PubMed         Abstract available


    Bone Marrow Transplant

  6. YAGI Y, Kanemasa Y, Goto H, Yamamoto M, et al
    Disease status at CAR T-cell infusion in relapsed or refractory large B-cell lymphoma: prognostic significance for real-world outcomes, irrespective of bridging therapy.
    Bone Marrow Transplant. 2026 Feb 14. doi: 10.1038/s41409-026-02802.
    PubMed        


    Br J Haematol

  7. PENA M, Lazzari L, Martinez DF, Ciceri F, et al
    Treosulfan/fludarabine versus thiotepa/busulfan/fludarabine for allogeneic haematopoietic cell transplantation in lymphoma in the post-transplant cyclophosphamide era: A GETH-TC study.
    Br J Haematol. 2026 Feb 12. doi: 10.1111/bjh.70367.
    PubMed         Abstract available

  8. WEI C, Zhang Y, Zhao D, Zhang W, et al
    Clonal haematopoiesis in T-follicular helper cell lymphoma: A prognostic biomarker and early event in lymphoma evolution.
    Br J Haematol. 2026 Feb 11. doi: 10.1111/bjh.70363.
    PubMed         Abstract available


    Cancer

  9. MANTZ L, Johnson PC, Lei M, Newcomb RA, et al
    Exploratory association of muscle and adipose tissue indices with clinical outcomes in aggressive lymphomas.
    Cancer. 2026;132:e70313.
    PubMed         Abstract available


    Cancer Lett

  10. SHI Q, Zhang M, He Y, Lin R, et al
    Corrigendum to "Baseline tumor-informed circulating tumor DNA concentration predicts early chemoimmunotherapy failure in diffuse large B-cell lymphoma" [Cancer Lett. 640 (2026) 218249].
    Cancer Lett. 2026 Feb 10:218297. doi: 10.1016/j.canlet.2026.218297.
    PubMed        


    Eur J Haematol

  11. ROBINSON R, Berger T, Shochat T, Aumann S, et al
    Obinutuzumab Maintenance in Follicular Lymphoma Is Associated With Better Progression Free Survival and Comparable Toxicity.
    Eur J Haematol. 2026 Feb 9. doi: 10.1111/ejh.70136.
    PubMed         Abstract available

  12. KEDMI M, Ribakovsky E, Porges T, Benjamini O, et al
    Nivolumab Maintenance for Aggressive B-Cell Lymphoma in Remission After First Line Therapy: A Phase 2 Clinical Trial.
    Eur J Haematol. 2026 Feb 11. doi: 10.1111/ejh.70132.
    PubMed        

  13. KHATIB H, Parizat A, Halloun J, Shouval R, et al
    Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS Onset.
    Eur J Haematol. 2026 Feb 12. doi: 10.1111/ejh.70139.
    PubMed         Abstract available


    Hum Pathol

  14. PARISI X, Medeiros LJ
    Follicular lymphoma with signet ring cell morphology: Clinicopathologic analysis of 31 cases.
    Hum Pathol. 2026;171:106071.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  15. MILGROM SA, Paganetti H, Dama H, Renfro L, et al
    Subsequent Neoplasm Risk after Modern Mediastinal Radiotherapy for Pediatric Hodgkin Lymphoma: Insights from a Multi-Institutional Children's Oncology Group Trial.
    Int J Radiat Oncol Biol Phys. 2026 Feb 6:S0360-3016(26)00361.
    PubMed         Abstract available


    J Am Acad Dermatol

  16. KIM DY, Dang TM, Huang JT, Stephen S, et al
    Increasing Incidence of Cutaneous T-Cell Lymphoma Among Children and Young Adults in the United States, 1997-2019: A National Population-Based Study Using the National Childhood Cancer Registry.
    J Am Acad Dermatol. 2026 Feb 11:S0190-9622(26)00185.
    PubMed        


    Lab Invest

  17. XIAO X, Dong J, Sun X, Jiang K, et al
    High-resolution Spatial Transcriptomic Characterization of Syncytial Variant of Nodular Sclerosis Classical Hodgkin Lymphoma.
    Lab Invest. 2026 Feb 13:106079. doi: 10.1016/j.labinv.2026.106079.
    PubMed         Abstract available


    Leukemia

  18. GAO J, Zhao X, Yin Q, Hu A, et al
    Synthetic lethality of MCL-1 inhibition and CAR-T therapy in aggressive B-cell lymphoma.
    Leukemia. 2026 Feb 12. doi: 10.1038/s41375-026-02884.
    PubMed         Abstract available


    Radiother Oncol

  19. ALI E, Simontacchi G, Levis M, Iori F, et al
    Low-Dose Radiotherapy for Primary Cutaneous Indolent B-Cell Lymphomas: a Multicenter Retrospective Study.
    Radiother Oncol. 2026;215:111327.
    PubMed         Abstract available

  20. HIGGINS MJ, Johnstone P, Prince HM, Lade S, et al
    Radiotherapy dose-response of mycosis fungoides with large cell transformation.
    Radiother Oncol. 2026;215:111292.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum